Accurately determining functional impairment of the respiratory system of scleroderma patients is essential to helping their recovery from symptoms. It…
Articles by Maureen Newman
Yuval Cohen (PhD), Chief Executive of Corbus Pharmaceuticals A new proposed treatment for scleroderma will soon be…
Richard Burt, MD, of Northwestern University is looking to harness the power of autologous, patient-derived stem…
Three key components of systemic sclerosis (SSc) are the subject of an ongoing clinical trial in University Hospital in…
Selexipag (ACT-293987), under development by Actelion, may be able to help individuals affected by “Raynaud’s…
A recruiting phase 2 clinical trial sponsored by Dinesh Khanna, MD, MS at the University of Michigan, in collaboration…
Important to the development of any treatment for scleroderma is a clinical study investigating the pharmacodynamics and pharmacokinetics of…
A Phase 1 clinical trial recently ended that involved “A Study of the Safety and…
As patients with scleroderma and Raynaud’s phenomenon know, cold hands can be extremely bothersome and even painful. Fredrick M.
“Zibotentan Better Renal Scleroderma Outcome Study (ZEBRA)” is more than a standard clinical trial for scleroderma…